Decheng Capital Global Healthcare Fund (Master), LP - 09 Nov 2023 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC.

Reporting relationship: 10%+ Owner
Issuer ticker: N/A
Reported as of: 09 Nov 2023
Net transaction value: +$4,687,500
SEC form: 4
Accepted by SEC: 14 Nov 2023, 17:36:42 UTC
Source filing: View source filing
Reporting owner signature: Decheng Capital Global Healthcare Fund (Master), LP, By Decheng Capital Global Healthcare GP, LLC, its General Partner, By Decheng Capital SV LLC, its Manager, By Decheng Capital LLC, its Manager, By /s/ Xiangmin Cui,...

Open signature details

Decheng Capital Global Healthcare Fund (Master), LP, By Decheng Capital Global Healthcare GP, LLC, its General Partner, By Decheng Capital SV LLC, its Manager, By Decheng Capital LLC, its Manager, By /s/ Xiangmin Cui, Manager

Key filing fact

Decheng Capital Global Healthcare Fund (Master), LP filed Form 4 for ALPINE IMMUNE SCIENCES, INC. on 14 Nov 2023.

Key facts

This page summarizes Decheng Capital Global Healthcare Fund (Master), LP's Form 4 filing for ALPINE IMMUNE SCIENCES, INC..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Nov 2023, 17:36.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$4,687,500.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALPN transaction

Common Stock

Purchase

Transaction value: $4,687,500
Shares: +375,000
Change %: +28%
Price: $12.50
Shares after: 1,735,544
Date: 09 Nov 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reportable securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare"). Decheng Capital Global Healthcare GP, LLC ("Healthcare GP") is the general partner of Healthcare. Xiangmin Cui is the indirect managing member and ultimate beneficial owner of Healthcare GP. Each of Healthcare, Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Healthcare GP disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein. Dr. Cui is a director of the Issuer and files separate Section 16 reports.